Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions
NCT ID: NCT05289505
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
83 participants
OBSERVATIONAL
2022-01-18
2023-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Music Listening in Radiotherapy Treatment
NCT03538223
Impact of Music Therapy on Anxiety in Patients With Cancer Undergoing Simulation for Radiation Therapy
NCT02150395
Effect of Music Intervention on Anxiety in Cancer Patients Undergoing Initial Radiation Therapy
NCT06115850
Music and Symptom Relief in Radiotherapy Patient
NCT06993441
Efficiency of Favourite Versus Predetermined Musical Sequence on Gynecology Pre-operative Anxiety
NCT03226834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prospective phase
This prospective phase involves all patients with an initial HADS score \> 7 and initiating treatment in the radiotherapy department. The treatment sessions will be performed with music, using the MUSIC-CARE device. In the event of technical problems, unavailability of equipment, or the patient's wishes, some radiotherapy sessions may be conducted without music. Nevertheless, a minimum of one weekly session with music is required for the analysis of the study.
MUSIC-CARE
This device allows the listening of music using different sequences of instrumental music created specifically, and using principles based on hypno-analgesia, that is to say the association of hypnotic techniques and approaches to help or analgesic, medicated or not. It consists of a tablet application containing instrumental music pieces, specially created and recorded for Music-Care. Each piece is at least 20 minutes long. The music can be played through headphones or speakers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MUSIC-CARE
This device allows the listening of music using different sequences of instrumental music created specifically, and using principles based on hypno-analgesia, that is to say the association of hypnotic techniques and approaches to help or analgesic, medicated or not. It consists of a tablet application containing instrumental music pieces, specially created and recorded for Music-Care. Each piece is at least 20 minutes long. The music can be played through headphones or speakers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing radiotherapy for curative treatment
* Patients with at least 15 sessions of radiotherapy
* Patients with an anxiety score \> 7 on the total A of the HADS scale at the time of medical consultation
Exclusion Criteria
* Pregnant or breastfeeding patients
* Patients with major hearing loss
* Patients with psychotic disorders
* Patients who do not understand or read the French language
* Patients under guardianship or deprived of liberty
* Patients requiring radiotherapy with respiratory servo-control (the MUSIC-CARE cannot be used due to technical constraints)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center Eugene Marquis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Coralie Hulot
Role: PRINCIPAL_INVESTIGATOR
Centre de Lutte contre le Cancer Eugène Marquis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Lutte contre le Cancer Eugène Marquis
Rennes, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00597-37
Identifier Type: REGISTRY
Identifier Source: secondary_id
2019-6-63-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.